Allarity Therapeutics Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250 Cambridge, MA U.S.A. - Allarity Therapeutics, Inc. , a clinical-stage. | April 22, 2022
Cambridge, MA U.S.A. (April 22, 2022) - Allarity Therapeutics, Inc. (Nasdaq: ALLR) ("Allarity" or the "Company"), a clinical-stage pharmaceutical company developing novel oncology therapeutics together
24.11.2021 - Press release Hørsholm, Denmark (November 24, 2021) Allarity Therapeutics A/S ( Allarity A/S or the Company ) hereby announces a voluntary offer and offer document to the shareholders of Allarity A/S to acquire all shares in Allarity A/S (the .